Page last updated: 2024-11-01

omeprazole and Facial Palsy

omeprazole has been researched along with Facial Palsy in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Research Excerpts

ExcerptRelevanceReference
"We report a hemifacial paralysis as an adverse drug reaction possibly related to the use of omeprazole in a patient with acute lymphoblastic leukemia."1.36Hemifacial paralysis in a child treated for leukemia: unusual side effect of omeprazole? ( Bauters, TG; Laureys, G; Mondelaers, V; Robays, H; Verlooy, J, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bauters, TG1
Verlooy, J1
Mondelaers, V1
Robays, H1
Laureys, G1

Other Studies

1 other study available for omeprazole and Facial Palsy

ArticleYear
Hemifacial paralysis in a child treated for leukemia: unusual side effect of omeprazole?
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2010, Volume: 16, Issue:2

    Topics: Adolescent; Child; Facial Paralysis; Humans; Male; Omeprazole; Precursor Cell Lymphoblastic Leukemia

2010